ELIZABETH PAPP: Open Payments
NPI 1114157211 · REDWOOD CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,213 in 49 payments from 10 companies in 2025. Trend: 2023 $1,125 · 2024 $946 · 2025 $1,213
Food & beverage: $1,213
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $337 |
| Regeneron Healthcare Solutions, Inc. | 11 | $256 |
| Amgen Inc. | 7 | $150 |
| GENZYME CORPORATION | 3 | $110 |
| Organon LLC | 3 | $93 |
| Janssen Biotech, Inc. | 3 | $77 |
| LEO Pharma Inc. | 3 | $73 |
| PFIZER INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 1 | $40 |
| Biofrontera Inc. | 1 | $21 |
Products named: DUPIXENT, RINVOQ, OTEZLA, SKYRIZI, TREMFYA, ADBRY, CIBINQO, BOTOX.
Industry payments across CA — which companies pay providers there.
